Hyperfractionated radiation therapy and cisplatin for locally-advanced head and neck cancer (LAHNC). Experience of the Hospital de Navarra

被引：0
|
作者：
Arias, F. [1 ]
Dominguez, M. A. [1 ]
Villafranca, E. [1 ]
Romero, P. [1 ]
Manterola, A. [1 ]
Martinez, E. [1 ]
Oria, E. [1 ]
Asin, G. [1 ]
Rico, M. [1 ]
Arraras, J. I. [1 ]
机构：
[1] Hosp Navarra, Navarra, Spain
来源：
EJC SUPPLEMENTS | 2007年 / 5卷 / 04期
关键词：
D O I：
10.1016/S1359-6349(07)71246-6
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5529
引用
收藏
页码：333 / 333
页数：1
相关论文
共 50 条
  • [1] Community outcomes: Hyperfractionated radiotherapy with concurrent cisplatin and locally-advanced head and neck cancer
    Maguire, PD
    [J]. CANCER JOURNAL, 2002, 8 (06): : 500 - 501
  • [2] Hyperfractionated radiation therapy and cisplatin for locally advanced head and neck cancer (LAHNC): a comparison among two consecutive protocols of treatment at a single-institution
    Arias, F
    Dominguez, M
    Villafranca, E
    Manterola, A
    Romero, P
    Martinez, E
    Oria, E
    Arraras, J
    Atienza, P
    Garcia-Bragado, F
    Medina, J
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (02): : S359 - S359
  • [3] Hyperfractionated radiotherapy with concurrent docetaxel in locally-advanced head and neck cancer
    Karasawa, K.
    Izawa, H.
    Hirowatari, H.
    Ito, K.
    Furuya, T.
    Ozawa, S.
    Matsumoto, F.
    Ito, S.
    Oba, S.
    Ikeda, K.
    [J]. EJC SUPPLEMENTS, 2009, 7 (02): : 480 - 480
  • [4] Concurrent chemotherapy and radiation therapy in locally-advanced head and neck cancer patients ⊠ a single institution experience
    Hamilton, R.
    Fontanesi, J.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2007, 82 : S55 - S55
  • [5] Cetuximab versus cisplatin concurrent with IMRT in locally advanced head and neck cancer (LAHNC)
    Galper, S. L.
    Deshpande, H.
    Rose, M. G.
    Decker, R. H.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [6] Sequential boost versus integrated boost intensity-modulated radiation therapy with concurrent chemotherapy for locally-advanced head and neck cancer (LAHNC).
    Cmelak, Anthony
    Stavas, Markj.
    Murphy, Barbara A.
    Shyr, Yu
    Gilbert, Jill
    Chen, Sheau-Chiann
    Vlacich, Gregory
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [7] Hypothyroidism as a consequence of intensity-modulated radiation therapy (IMRT) with concurrent taxane-based chemotherapy for locally-advanced head and neck cancer (LAHNC)
    Diaz, R.
    Jaboin, J. J.
    Stinson, S.
    Gilbert, J.
    Chung, C. H.
    Murphy, B. A.
    Burkey, B.
    Netterville, J.
    Yarbrough, W. G.
    Murphy, P. B.
    Cmelak, A. J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [8] Intensity-modulated radiation therapy (IMRT) with cocurrent taxane-based chemotherapy for locally-advanced head and neck cancer (LAHNC): Toxicities and efficacy
    Diaz, R.
    Thorpe, S. W.
    Murphy, B. A.
    Kirby, W.
    Burkey, B. B.
    Chung, C. H.
    Shakhtour, B.
    Murphy, P.
    Beach, M.
    Cmelak, A. J.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : S464 - S464
  • [9] Hyperfractionated accelerated radiotherapy in combination with weekly cisplatin for locally advanced head and neck cancer
    Beckmann, GK
    Hoppe, F
    Pfreundner, L
    Flentje, MP
    [J]. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2005, 27 (01): : 36 - 43
  • [10] Outcomes and Late Effects: A Comparison of Patients with Locally-advanced Head and Neck Cancer (LAHNC) Treated with Cisplatin (CDDP) and Radiation (RT) vs. Cetuximab (C) and RT
    Koutcher, L. D.
    Fury, M.
    Sherman, E.
    Wolden, S.
    Zhang, Z.
    Mo, Q.
    Zelefsky, M.
    Kraus, D.
    Pfister, D.
    Lee, N.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03): : S180 - S180
12345